BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11558535)

  • 1. Experimental chemotherapy against canine mammary cancer xenograft in SCID mice and its prediction of clinical effect.
    Yamashita A; Maruo K; Suzuki K; Shirota K; Kobayashi K; Hioki K
    J Vet Med Sci; 2001 Aug; 63(8):831-6. PubMed ID: 11558535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice.
    Papadopoulou MV; Ji M; Bloomer WD
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):160-8. PubMed ID: 11561782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing].
    Sagawa T; Yamashita K; Kawamura M; Shimizu T; Haga H; Yorozu Y; Kasamo M; Fujita M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.
    Cemazar M; Auersperg M; Scancar J; Kirbis IS; Pogacnik A; Sersa G
    J Pharmacol Exp Ther; 2002 Jul; 302(1):337-43. PubMed ID: 12065735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
    Yamauchi T; Okada K; Yoshida O
    Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
    Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T
    Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C; Overgaard J
    Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
    Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.
    Uchida N; Takeda Y; Kasai H; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1998; 18(5A):3375-9. PubMed ID: 9858911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
    Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.
    Simon D; Knebel JW; Baumgartner W; Aufderheide M; Meyer-Lindenberg A; Nolte I
    Am J Vet Res; 2001 Nov; 62(11):1825-30. PubMed ID: 11703031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
    Fujimoto S; Chikazawa H
    Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic treatment of xenograft Spirocerca lupi-associated sarcoma in a murine model.
    Stettner N; Ranen E; Dank G; Lavy E; Brenner O; Harmelin A
    Comp Med; 2007 Jun; 57(3):267-71. PubMed ID: 17605341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
    Tsukuda M; Mochimatsu I; Kokatsu T; Ito K; Furukawa S; Inoue T; Watanabe S; Sawaki S
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
    Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.